Artwork
iconShare
 
Manage episode 507365891 series 3679834
Content provided by Pink Elephant Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pink Elephant Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the maturation of the industry beyond the hype, and the massive commercial hurdles that many are overlooking. A candid and insightful look at investment, innovation, and what it really takes to bring psychedelic therapies to patients.
#PsychedelicInvesting #PsychedelicMedicine #DrugDevelopment #MentalHealthInnovation #FDA #PsychedelicStartups #MentalHealthPodcast
In this insightful conversation, Maria shares:
Her unique journey from a decade in Big Pharma to launching a psychedelic-focused venture fund.
Why the biggest opportunities are in the "picks and shovels"—the enabling technologies and infrastructure.
The major hurdles after FDA approval: therapist training and insurance coverage.
How the industry has moved from a hype curve to a new stage of maturity.
Why Big Pharma's entry is a game-changer and a sign of what's to come.
The overlooked but crucial role of patent strategy for long-term success.
Future frontiers for innovation: AI in drug development and psychedelic applications in women's health.
00:00 Intro
01:09 Maria's Journey: From Big Pharma to Psychedelic VC
04:22 Why the Psychedelic Industry is Maturing, Not Plateauing
08:14 The "Picks and Shovels": Real Money is in Infrastructure
12:50 The Biggest Hurdle After Approval: Insurance Coverage
18:30 Is the Stigma Around Psychedelics Disappearing?
23:45 Why Capital is Coming Back to the Space
27:21 The Future: AI's Role in Drug Development
29:55 A Massive Untapped Market: Psychedelics for Women's Health
34:54 The Overlooked Importance of Patent Strategy
44:55 What to Expect in the Next 1-2 Years
Whether you're an entrepreneur, therapist, investor, or just curious about the psychedelic renaissance, this episode offers a rare inside look at the business realities and future opportunities beyond the mainstream headlines.
https://www.linkedin.com/in/maria-velkova/
https://www.tabularasa.ventures/
Like what you heard? Hit subscribe and follow us for more in-depth insights into the future of mental health -- https://www.youtube.com/@Evolving_Minds_Podcast
Stay tuned with our channels:
Spotify: https://open.spotify.com/show/0lOYS1R9bu7plbF65sbR5u
Apple Podcast: https://podcasts.apple.com/us/podcast/evolving-minds-by-pink-elephant/id1829115616
LinkedIn: https://www.linkedin.com/company/pink-elephant-fund/
Twitter: https://x.com/PE_PinkElephant
The Evolving Minds podcast by Pink Elephant, hosted by Jason Najum, is a series of 1-on-1 conversations with star guests who dare to build, scale, or rethink companies, policies, and protocols at the frontier of progressive mental health.

  continue reading

3 episodes